Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 3, 1973 - Issue 6
3
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Studies on [8-14C]Adenosine-5′-Carboxylic Acid Ethyl Ester: I. Metabolic Fate in the Dog, Rat and Mouse

&
Pages 381-388 | Received 16 Mar 1973, Published online: 14 Oct 2008
 

Abstract

1. [8-14C]Adenosine-5-carboxylic acid ethyl ester ([8-14C]ACAEE) when administered orally to the dog and rat was rapidly absorbed. Plasma half-lives of 14C showed that the drug and/or its metabolites were eliminated from plasma at a rapid rate by the rat and somewhat slower by the dog.

2. Urinary elimination of labelled metabolites by the rat and mouse were complete by 4 days. The dog eliminated the majority of the 14C-dose by 3 days but slowly excreted the rest of the dose for at least 24 days.

3. Separation of the urinary metabolites on columns of AGI (formate) basic resin and Dowex 50 (H+) acidic resin revealed a high degree of similarity in the metabolic patterns of [8-14C] ACAEE in the dog, rat and mouse. Two metabolites were identified, the major one, accounting for 80–90% total radioactivity, was adenosine-5′-carboxylic acid; the second metabolite, inosine-5′-carboxylic acid, contained 6–16% of the radioactivity.

4. Glusulase was shown to enzymically deaminate adenosine-5′-carboxylic acid into inosine-5′-carboxylic acid.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.